VAERS Explorer
Back to explore

Report #2879558

Received Dec 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
FL
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (7)

TypeNameManufacturerDoseLotRoute / Site
DTAPDTAP (INFANRIX)GLAXOSMITHKLINE BIOLOGICALSUNK——
DTAPHEPBIPDTAP + HEPB + IPV (PEDIARIX)GLAXOSMITHKLINE BIOLOGICALSUNK——
DTAPIPVDTAP + IPV (KINRIX)GLAXOSMITHKLINE BIOLOGICALSUNK——
HEPHEP B (ENGERIX-B)GLAXOSMITHKLINE BIOLOGICALSUNK——
HIBVHIB (HIBERIX)GLAXOSMITHKLINE BIOLOGICALSUNK——
MNQMENINGOCOCCAL CONJUGATE (MENVEO)NOVARTIS VACCINES AND DIAGNOSTICSUNKUNK—
TDAPTDAP (BOOSTRIX)GLAXOSMITHKLINE BIOLOGICALSUNK——

Symptoms (1)

Product storage error

Symptom narrative

Vaccine stored outside recommended conditions and administered to patient.; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. Co-suspect products included HBV (Engerix B) for prophylaxis, Hib (Hiberix) for prophylaxis, DTPa (Infanrix) for prophylaxis, DTPa-IPV (Kinrix) for prophylaxis, Men ACWY-CRM NVS (Menveo) for prophylaxis and DTPa-HBV-IPV (Pediarix) for prophylaxis. On an unknown date, the patient received Boostrix, Engerix B, Hiberix, Infanrix, Kinrix, Menveo and Pediarix. On an unknown date, an unknown time after receiving Boostrix, Engerix B, Hiberix, Infanrix, Kinrix, Menveo and Pediarix, the patient experienced incorrect storage of drug (Verbatim: Vaccine stored outside recommended conditions and administered to patient.). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date 15-DEC-2025 On 16th October 2025 the vaccines Bexsero, Boostrix, Engerix-B, Hiberix, Infanrix , Kinrix, Menveo (1-vial) and Pediarix experienced a temperature excursion. The vaccines reached a temperature of 55.9 degree F for a cumulative time of 3 hours. The vaccines were administered. The reporter did not consent to follow-up. The batch number was not provided upon follow- up with the reporter.